Iqbal O - Search Results

1

Reference ranges of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisited.

Gerbutavicius R, Fareed J, Messmore HL, Iqbal O, Wehrmacher WH, Hoppensteadt DA, Demir M, Piccolo P, Ahmad S, Ma Q, Griniute R. Gerbutavicius R, et al. Among authors: iqbal o. Clin Appl Thromb Hemost. 2002 Jan;8(1):51-9. doi: 10.1177/107602960200800107. Clin Appl Thromb Hemost. 2002. PMID: 11991240 Free article.

2

The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model.

Bacher P, Welzel D, Iqbal O, Hoppensteadt D, Callas D, Walenga JM, Fareed J. Bacher P, et al. Among authors: iqbal o. Thromb Res. 1992 May 1;66(2-3):151-8. doi: 10.1016/0049-3848(92)90185-d. Thromb Res. 1992. PMID: 1329252

3

Pharmacodynamics of a sulfated lactobionic acid amide-derived antithrombotic agent (Aprosulate) in primates.

Fareed J, Coker S, Iqbal O, Hoppensteadt D, Walenga JM. Fareed J, et al. Among authors: iqbal o. Semin Thromb Hemost. 1991;17 Suppl 2:147-52. Semin Thromb Hemost. 1991. PMID: 1948085 No abstract available.

4

Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins.

Jeske W, Lormeau JC, Callas D, Iqbal O, Hoppensteadt D, Fareed J. Jeske W, et al. Among authors: iqbal o. Semin Thromb Hemost. 1995;21(2):193-200. doi: 10.1055/s-2007-1000395. Semin Thromb Hemost. 1995. PMID: 7660142

5

Pharmacologic validation of the clinical effects of an optimized low-molecular-weight heparin-reviparin.

Fareed J, Jeske W, Eschenfelder V, Iqbal O, Hoppensteadt D, Ahsan A. Fareed J, et al. Among authors: iqbal o. Semin Thromb Hemost. 1995;21(2):212-27. doi: 10.1055/s-2007-1000397. Semin Thromb Hemost. 1995. PMID: 7660144

6

Evaluation of hemostatic and fibrinolytic alterations associated with daily administration of low-molecular-weight heparin for a 12-week period.

Lojewski B, Bacher P, Iqbal O, Walenga JM, Hoppensteadt D, Leya F, Fareed J. Lojewski B, et al. Among authors: iqbal o. Semin Thromb Hemost. 1995;21(2):228-39. doi: 10.1055/s-2007-1000398. Semin Thromb Hemost. 1995. PMID: 7660145

7

Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.

Callas D, Bacher P, Iqbal O, Hoppensteadt D, Fareed J. Callas D, et al. Among authors: iqbal o. Thromb Res. 1994 May 1;74(3):193-205. doi: 10.1016/0049-3848(94)90108-2. Thromb Res. 1994. PMID: 8042188

8

Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide.

Callas DD, Hoppensteadt DA, Jeske W, Iqbal O, Bacher P, Ahsan A, Fareed J. Callas DD, et al. Among authors: iqbal o. Semin Thromb Hemost. 1993;19 Suppl 1:49-57. Semin Thromb Hemost. 1993. PMID: 8362269 No abstract available.

9

A comparison of the pharmacokinetic and pharmacodynamic profiles of Clexane and Lovenox in dogs.

Iqbal O, Jeske W, Bacher P, Hoppensteadt DA, Walenga JM, Fareed J. Iqbal O, et al. Semin Thromb Hemost. 1993;19 Suppl 1:199-209. Semin Thromb Hemost. 1993. PMID: 8395722 No abstract available.

10

Evaluation of hematologic alterations associated with daily administration of low molecular weight heparin (Mono-Embolex) for a 12-week period.

Lojewski B, Bacher P, Iqbal O, Walenga JM, Hoppensteadt DA, Leya F, Fareed J. Lojewski B, et al. Among authors: iqbal o. Semin Thromb Hemost. 1993;19 Suppl 1:36-43. Semin Thromb Hemost. 1993. PMID: 8395730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters